This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Hand (embryology)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Upper limb specification largely occurs during weeks four to six of embryogenesis. The majority of upper limb anomalies are produced at this stage of development. The limb bud develops from the migration of undfferentiated lateral plate somatic mesoderm into the overlying ectoderm in the region of the eighth to tenth somites along the lateral margin of the embryo. This region forms a 'morphogenetic field', that is a volume of cells which undergo similar forms of development as they lie within the same set of boundaries. Within the morphogenetic field of the limb bud, Hox gene expression makes cells competent to respond to the influence of different morphogen signals. The ectoderm thickens at this site to form the apical ectodermal ridge (AER). The AER acts as one of the signalling centers for further limb development.

Further development is orchestrated by a highly complex and stereotyped sequence of morphogen proteins that are part of separate signalling pathways. With some interplay of influence, discrete systems govern patterning of different anatomical axes:

  • proximal to distal
  • anterior to posterior
  • dorsal to ventral

 


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.